| 1. |
Sibutramine improves cardiovascular risk profile |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 2. |
Antibacterial use in EU countries varies > 4-fold |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 3. |
Lower resource use with anti-inflammatories in paediatric asthma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 4. |
Memantine improves function and cognition in advanced Alzheimer's |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 5-5
Ed Susman,
Preview
|
|
摘要:
The latest results with the NMDA receptor antagonist memantine show that it markedly reduces disease progression in patients with advanced Alzheimer's disease, compared with placebo. At the 154th Annual Meeting of the American Psychiatric Association [New Orleans, US; May 2001], researchers said that when patients received memantine, the first nonacetylcholinesterase inhibitor to approach the US market, their scores on measures of daily living and global functioning remained significantly higher than scores among placebo recipients.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 5. |
... and cardiac manifestations of Fabry's disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 6. |
New tricks with targeted therapies for cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 7-8
Carmen Innes,
Preview
|
|
摘要:
Molecularly targeted therapies for cancer were definitely hot news at this year's Annual Meeting of the American Society of Clinical Oncology (ASCO) [San Francisco, US; May 2001]. The most significant results to be presented were those of STI 571 in patients with gastrointestinal stromal tumours (GISTs), reported in last week's issue ofInpharma.*However, other molecularly targeted therapies were also highlighted. Preliminary data reveal that a vaccine made from patients' genetically altered tumour cells results in a dramatic regression of disease in patients with advanced colorectal cancer. Results from another early trial show that the genetically modified vaccine 'GVAX' may stop or even reverse the progression of cancer in patients with non-small-cell lung cancer (NSCLC) who are refractory to other therapies. Finally, cetuximab [IMC-C225], a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has activity in patients with colorectal cancer resistant to standard therapy.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 7. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 8. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 9. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 10. |
Challenging standard therapy for bladder and aerodigestive cancers |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1292,
2001,
Page 11-12
Carmen Innes,
Preview
|
|
摘要:
Studies revealing important advances in the treatment of cancers of the bladder and aerodigestive tract were reported recently at the 37th Annual Meeting of the American Society of Clinical Oncology [San Francisco, US; May 2001]. In the first study, median survival nearly doubled in patients with locally advanced bladder cancer who were treated with chemotherapy before surgical removal of the bladder, compared with patients treated with surgery alone, the current standard of care. A second study has shown that patients with locally advanced cancer of the larynx treated simultaneously with chemotherapy and radiotherapy preserve the use of their larynx significantly longer than patients treated with traditional therapy. Finally, the addition of a short course of chemotherapy before surgery results in a significant improvement in survival in patients with oesophageal cancer, compared with surgery alone.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
首页
